Ricke, Jens, MD
Professor and Chairman, Department of Radiology University Hospital Munich
Jens Ricke is Professor of Medicine at the University Hospital Munich and chair of the department of radiology.
His research interests include in particular clinical minimally invasive oncology / cancer therapy, including the development of interventional radiology by means of image-guided microtherapy.
Ricke’s research group has pushed the development and clinical introduction of image-guided, micro-therapeutic interventions, especially in the field of oncology. Activities include basic research in synergisms of immune-oncology and interventional oncology, as well as preclinical development and clinical validation of image guided technologies and their respective outcomes in the according patient groups. As director of the Dept. of Radiology of the Ludwig-Maximilans-University in Munich, his responsibilities include both diagnostic and interventional radiology in one of Germany´s leading University hospitals.
Prof. Jessica Zucman-Rossi
University Paris Descartes
Jessica Zucman-Rossi is Professor of Medicine at University Paris Descartes, within the depatment of Oncology at the European Hospital Geaorges Pompidou (AP-HP). She is the director of an INSERM laboratory “Functional Genomics of Solid Tumors”, with a focus on liver, mesothelial and renal tumors. Her team aims to develop basic genomic approaches based on human tumors analyses to identify new mechanisms of tumorigenesis and to transfer this knowledge into biomarkers that could be introduced in clinical care. In particular, the group was pioneer in the elucidation of the molecular classification of benign and malignant liver tumors. Currently, she is executive secretary of ILCA (International Liver Cancer Association) and she acts as co-Editor for Journal of Hepatology.
Professor Edward K. Geissler, PhD
Head of Experimental Surgery, Department of Surgery
University Hospital Regensburg, Germany
Edward Geissler is a scientist at the University of Regensburg working in different areas spanning the field of Transplantation including basic immunology and tolerance, solid organ transplantation, immunosuppressive therapies and post-transplant malignancy. He has focussed on the understanding and prevention of immunologic rejection of transplanted organs and on novel, as well as conventional, immunosuppressive therapies to prevent transplant rejection. He also has an interest in post-transplant development of cancer, and has made a strong translational research effort through molecular targeting to reduce the threat of malignancies in transplant recipients. In another effort to reduce the burden of immunosuppressive drugs, he is leading an initiative to introduce cellular therapy in transplant recipients. Transfer of new ideas from the basic research lab to the transplant recipient is a central theme of his work
Prof. Daniel Sherqui
Department of Digestive Surgery - Hôpital Henri Mondor - University Paris XII
Prof. Daniel Cherqui is currently Professor of Surgery at Université Paris-Sud and Surgical
Director of Liver Transplantation at Paul Brousse Hospital in Villejuif-Paris France. He is an
internationally renowned expert in liver transplantation and liver resection. Prof. Cherqui
received his surgical training at the University of Paris and completed a liver transplant
fellowship in Prof. Henri Bismuth’s Unit in 1986 and at the University of Chicago in Prof
Christoph Broelsch’s Unit in 1987. In 1988, he was recruited to start a Liver Transplantation
and HPB Surgery Program at Henri Mondor Hospital in Créteil-Paris where he became
Chairman of General Surgery in 2005. In 2010, he moved to Weill Cornell Medical Center in
New York, NY USA, as Chief of HPB Surgery and Liver Transplantation. In 2013, he moved
back to France and joined Paul Brousse Hospital, home of the largest liver transplant
program in France. He has published extensively and is considered one of the pioneers of
laparoscopic liver surgery. He is the Founding President of the “International Laparoscopic
Liver Society”.
Myron E. Schwartz, MD
The Henry Kaufmann Professor of Surgery
Director of Liver Surgery
Recanati/Miller Transplantation Institute, The Mount Sinai Medical Center, New York
Dr. Schwartz graduated from Jefferson Medical College AOA in 1976. After a year of rotating internship he joined the National Health Service Corps for three years as a general practitioner in rural Virginia. Dr. Schwartz came to Mount Sinai in 1981, completed residencies in general and vascular surgery, and joined the faculty in 1987. He worked with Charles Miller, MD to establish the Mount Sinai Liver Transplant Program in 1988, and since then has devoted his career to hepatobiliary surgery and transplantation. Over the years he has served as Director of Pediatric and Adult Liver Transplantation, and more recently has focused on liver cancer. Dr. Schwartz is currently the Clinical Director of the Mount Sinai Liver Cancer Program. Together with Research Director Josep Llovet MD, Dr Schwartz has led the collaborative effort that has put Mount Sinai at the forefront world-wide in liver cancer clinical care and clinical/translational research. Dr Schwartz has been funded by the NIH through a K24 Career Development Award entitled, “Systematic Integration of Patient-Oriented Research into the Clinical Pathway for Hepatocellular Carcinoma”. He has published over 300 papers in peer-reviewed journals, as well as 21 book chapters. Dr. Schwartz is an international authority on hepatic resection and transplantation for liver cancer, a subject about which he lectures frequently both in the U.S. and around the world. Dr. Myron Schwartz – Director of Hepatobiliary Surgery ,Mount Sinai Medical Center, NY.